Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients-Reference-Cited by-同舟云学术

Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients

Published:2021-03-01 Issue:4 Volume:21 Page:491-497
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Demurtas Sara^ORCID,La Verde Nicla,Rota Selene,Casazza Giovanni,Montrasio Cristina,Cheli Stefania^ORCID,Cona Maria Silvia,Dalu Davide^ORCID,Fasola Cinzia,Ferrario Sabrina,Filipazzi Virginio,Gambaro Anna,Tosca Nicoletta,Clementi Emilio

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/s41397-021-00227-7.pdf

Reference34 articles.

1. De Weger VA, Beijnenb JH, Schellensa JHM. Cellular and clinical pharmacology of the taxanes docetaxel and paclitaxel—a review. Anticancer Drugs. 2014;25:488–94.

2. Ma P, Mumper RJ. Paclitaxel nano-delivery systems: a comprehensive review. J Nanomed Nanotechnol. 2013;4:164.

3. Sparano JA, Wang M, Martino S, Jones V, Perez EA, Saphner T, et al. Weekly paclitaxel in the adjuvant treatment of breast cancer. N. Engl J Med. 2008;358:1663–71.

4. Kudlowitz D, Muggia F. Defining risks of taxane neuropathy: insights from randomized clinical trials. Clin Cancer Res. 2013;19:4570–7.

5. Guo X, Sun H, Dong J, Feng Y, Li H, Zhuang R, et al. Does nab-paclitaxel have a higher incidence of peripheral neuropathy than solvent-based paclitaxel? Evidence from a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2019;139:16–23.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation/Inactivation of Anticancer Drugs by CYP3A4: Influencing Factors for Personalized Cancer Therapy;Drug Metabolism and Disposition;2023-02-02

2. Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark;Breast Cancer Research and Treatment;2022-04-30